| Literature DB >> 26406475 |
Maria Liljeroos1, Susanna Ågren2, Tiny Jaarsma3, Kristofer Årestedt4, Anna Strömberg5.
Abstract
BACKGROUND: To date, contemporary heart failure care remains patient-focused, but awareness of the partners' and families' situation is increasing. Randomized studies have mainly evaluated the short-term effects of dyadic interventions. Therefore, the aim of this study was to determine the 24-month effects of an intervention with psych-educational support in dyads of heart failure patients and their partners.Entities:
Mesh:
Year: 2015 PMID: 26406475 PMCID: PMC4583392 DOI: 10.1371/journal.pone.0138058
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Description of the modules in the intervention.
| Module 1 | Module 2 | Module 3 | |
|---|---|---|---|
|
| The circulatory system, definition of HF, medications and symptom management | Lifestyle modifications; diet, smoking cessation, alcohol, immunization, regular exercise | Directing the care, relationship and prognosis |
|
| Increased knowledge of the chronic HF syndrome and treatment | Increased knowledge of the rationale for lifestyle changes | Increased knowledge of self-care and outcomes |
|
| Introduce psychosocial support concept | Assess patient’s need of support, Modify caregiver behavior | Assess partner’s need of support and partner’s caregiver burden |
|
| Improved mental and physical functions | Strengthen self-care behaviour | Improved mutual support Decreased caregiver burden Improved control |
|
| Intentions, abilities and self-efficacy regarding self-care | Barriers to lifestyle modifications | Strategies to improve or maintain self-care behaviour |
|
| Daily weighing, Monitoring of symptoms, Flexible diuretic intake, Adherence | Salt and fluid restriction, Influenza and Pneumococcal Immunisations Regular Exercise | Identifying life priorities and planning for the future |
Content of each of the three modules utilised in the intervention.
Fig 1Flowchart for the participating dyad from enrolment until 24 months.
Clinical and demographic characteristics of the patient-partner dyads at baseline.
| Control | Intervention | |||
|---|---|---|---|---|
| Characteristics | Patient (n = 84) | Partner (n = 84) | Patient (n = 71) | Partner (n = 71) |
| Age, mean±SD | 72.9±10.1 | 69.5±10.5 | 69.4±13.6 | 67.1±12.1 |
| Female, n (%) | 16 (19,1) | 68 (80,9) | 22 (30,9) | 49 (69,1) |
|
| ||||
| Myocardial infarction | 38 (43) | 13 (15) | 23 (33) | 8 (11) |
| Hypertension | 26 (31) | 25 (30) | 27 (38) | 25 (35) |
| Diabetes | 10 (12) | 4 (5) | 8 (11) | 7 (10) |
| Stroke | 8 (10) | 4 (5) | 9 (13) | 3 (4) |
| Lung disease | 7 (8) | 10 (12) | 3 (42) | 1 (1) |
| Pacemaker | 9 (11) | 1 (1) | 11 (15) | 1 (1) |
| Cardiac resynchronization therapy | 15 (18) | 1 (1) | 8 (11) | 0 (0) |
| Implantable cardioverter defibrillator | 2 (2) | 0 (0) | 3 (4) | 0 (0) |
| Percutaneous coronary intervention | 15 (18) | 3 (4) | 10 (14) | 3 (4) |
| Coronary artery bypass surgery | 17 (20) | 3 (4) | 12 (17) | 2 (3) |
|
| ||||
| II | 25 (30) | 24 (35) | ||
| III | 43 (51) | 40 (55) | ||
| IV | 16 (19) | 7 (10) | ||
|
| ||||
| ACEI/ARB | 76 (90) | 65 (92) | ||
| Beta-blockers | 74 (88) | 62 (87) | ||
| Diuretics | 63 (75) | 56 (79) | ||
|
| ||||
| Elementary school | 56 (65) | 48 (58) | 40 (59) | 41 (59) |
| High school | 21 (26) | 22 (28) | 22 (32) | 26 (37) |
| University | 7 (9) | 14 (14) | 9 (9) | 4 (4) |
| Years at school, mean±SD | 9.8±6.1 | 9.9±3.5 | 9.4±4.7 | 9.7±3.2 |
|
| ||||
| Full time | 10 (11) | 18 (20) | 10 (14) | 22 (33) |
| Disability pension/sick leave | 10 (11) | 4 (5) | 13 (17) | 2 (3) |
| Homemaker | 3 (2) | 0 (0) | 1 (1) | 2 (3) |
| Pension | 61 (76) | 62 (75) | 47 (68) | 45 (61) |
|
| ||||
| Smoking/ Ex-smoking | 47 (60) | 39 (49) | 36 (54) | 30 (42) |
| Alcohol Never drink alcohol | 20 (26) | 18 (23) | 16 (24) | 15 (23) |
| ≤7 glass/week | 54 (71) | 57 (74) | 45 (67) | 46 (69) |
| > 7 glass/week | 3 (3) | 2 (3) | 6 (9) | 5 (8) |
| Unknown | 7 | 7 | 4 | 5 |
| Exercise < 30 min/week | 27 (36) | 6 (8) | 13 (20) | 4 (6) |
| 30 min-3 hours/week | 25 (31) | 28 (36) | 36 (42) | 29 (43) |
| > 3 hours/week | 26 (33) | 43 (56) | 19 (28) | 35 (51) |
| Unknown | 6 | 7 | 3 | 3 |
| BMI, mean±SD | 26.8±4.1 | 26.8±4.1 | 26.6±4.5 | 26.6±4.9 |
a Lung disease was significantly (p <0.05) more common in the partner control group compared to the partner intervention group.
Readmissions and reason for readmissions during the 24- month’s follow-up period.
| Control patient, n = 84 | Intervention patient, n = 71 | p-value | |
|---|---|---|---|
| Readmitted 24 months, n (%) | 58 (68) | 51 (72) | 0.72 |
| Days to first readmission, mean (SD) | 403.5±282.5 | 345.6±282.7 | 0.09 |
| Number of readmissions, mean (SD) | 1.6±1.6 | 1.8±1.9 | 0.70 |
| Number of days in hospital, mean (SD) | 4.0±14.0 | 4.0±15.0 | 0.50 |
| Hospitalization ≤2 days, n (%) | 19 (37.3) | 21 (44.7) | 0.54 |
| Hospitalization >2 days, n (%) | 32 (62.7) | 26 (55.3) | 0.41 |
|
| |||
| Heart failure, n (%) | 33 (34) | 31 (38) | 0.64 |
| Heart disease, n (%) | 41 (43) | 41 (49,3) | 0.52 |
| Other reason, n (%) | 26 (27) | 28 (34) | 0.29 |
Student’s t- test was used for continuous variables, presented as mean ± standard deviation (SD). Categorical variables are given as percent (%) and are compared using Chi-square test.
Multiple linear regression analyses (robust variance estimates) to detect intervention effects regarding health, symptoms of depression and perceived control for both patients and partners.
| Outcome variables | Group | Mean diff (SD) | β (SE) | 95% CI for β | p-value |
|---|---|---|---|---|---|
| PCS (n = 183) | Intervention group | -2.67 (0.93) | -1.08 (1.31) | -3.68 / 1.53 | 0.415 |
| Control group | -1.60 (0.96) | ||||
| MCS (n = 183) | Intervention group | 3.49 (1.10) | 0.94 (1.79) | -2.61 / 4.49 | 0.601 |
| Control group | 2.56 (1.20) | ||||
| PF (n = 189) | Intervention group | -4.28 (2.26) | -2.80 (2.83) | -8.41 / 2.81 | 0.325 |
| Control group | -1.48 (1.88) | ||||
| RP (n = 187) | Intervention group | -3.50 (4.57) | -1.82 (6.42) | -14.56 / 10.92 | 0.777 |
| Control group | -1.68 (4.12) | ||||
| BP (n = 190) | Intervention group | -3.33 (2.91) | -2.56 (4.67) | -11.83 / 6.72 | 0.586 |
| Control group | -0.77 (3.04) | ||||
| GH (n = 190) | Intervention group | -0.18 (2.07) | 2.40 (3.01) | -3.58 / 8.37 | 0.428 |
| Control group | -2.58 (1.85) | ||||
| VT (n = 189) | Intervention group | 5.23 (2.18) | 2.34 (3.25) | -4.11 / 8.78 | 0.473 |
| Control group | 2.89 (2.19) | ||||
| SF (n = 190) | Intervention group | 1.40 (2.36) | -3.17 (3.53) | -10.19 / 3.84 | 0.371 |
| Control group | 4.58 (2.48) | ||||
| RE (n = 186) | Intervention group | 7.66 (4.32) | 2.61 (6.25) | -9.80 / 15.02 | 0.677 |
| Control group | 5.05 (4.15) | ||||
| MH (n = 189) | Intervention group | 3.30 (1.89) | 0.43 (3.01) | -5.56 / 6.41 | 0.888 |
| Control group | 2.87 (1.89) | ||||
| BDI (n = 133) | Intervention group | 0.66 (0.68) | -0.06 (1.34) | -2.74 / 2.63 | 0.967 |
| Control group | 0.71 (0.98) | ||||
| CAS (n = 183) | Intervention group | 2.33 (0.52) | 0.65 (0.76) | -0.85 / 2.15 | 0.395 |
| Control group | 1.69 (0.48) |
a Control group as reference category.
b Mean difference between the baseline and 24-month follow-up assessment.
c Robust standard errors (robust variance estimates).
PCS = SF-36 physical component scale, MCS = SF-36 mental component scale, PF = physical functioning, RP = role limitations due to physical health problems, BP = bodily pain, GH = general health, VT = vitality, SF = social functioning, RE = role limitations due to emotional problems and MH = mental health, BDI = Beck Depression Inventory, CAS = Control Attitude Scale.